Amelioration of Colitis in Mouse Model by Exploring Antioxidative Potentials of an Indigenous Probiotic Strain of Lactobacillus fermentum Lf1
- 2015-03-12
- Clinical Trial
- BioMed Research International 2014
- Ritu Chauhan
- A. Vasanthakumari
- Harsh Panwar
- R. H. Mallapa
- R. Duary
- V. Batish
- S. Grover
- PubMed: 25061603
- DOI: 10.1155/2014/206732
- Low evidence
- Animal Study
The Lf1-treated group had decreased malondialdehyde level as compared to colitis control (37.92 ± 6.31 versus 91.13 ± 5.76 μM/g).
- Effect
- Beneficial
- Effect size
- Large